Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
- PMID: 15953931
- DOI: 10.1038/nrmicro1179
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
Abstract
Like other microorganisms, fungi exist in populations that are adaptable. Under the selection imposed by antifungal drugs, drug-sensitive fungal pathogens frequently evolve resistance. Although the molecular mechanisms of resistance are well-characterized, there are few measurements of the impact of these mechanisms on pathogen fitness in different environments. To predict resistance before a new drug is prescribed in the clinic, the full spectrum of potential resistance mutations and the interactions among combinations of divergent mechanisms can be determined in evolution experiments. In the search for new strategies to manage drug resistance, measuring the limits of adaptation might reveal methods for trapping fungal pathogens in evolutionary dead ends.
Similar articles
-
Population dynamics and the evolution of antifungal drug resistance in Candida albicans.FEMS Microbiol Lett. 2012 Aug;333(2):85-93. doi: 10.1111/j.1574-6968.2012.02587.x. Epub 2012 May 21. FEMS Microbiol Lett. 2012. PMID: 22540673 Review.
-
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.FEMS Yeast Res. 2009 Oct;9(7):1029-50. doi: 10.1111/j.1567-1364.2009.00578.x. Epub 2009 Sep 7. FEMS Yeast Res. 2009. PMID: 19799636 Review.
-
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.Nat Rev Microbiol. 2008 Mar;6(3):187-98. doi: 10.1038/nrmicro1835. Nat Rev Microbiol. 2008. PMID: 18246082 Review.
-
Evolution of drug resistance in Candida albicans.Annu Rev Microbiol. 2002;56:139-65. doi: 10.1146/annurev.micro.56.012302.160907. Epub 2002 Jan 30. Annu Rev Microbiol. 2002. PMID: 12142485 Review.
-
Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.Int J Antimicrob Agents. 2006 Jul;28(1):69-74. doi: 10.1016/j.ijantimicag.2006.02.016. Epub 2006 Jun 19. Int J Antimicrob Agents. 2006. PMID: 16782311
Cited by
-
The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance.PLoS One. 2012;7(9):e44734. doi: 10.1371/journal.pone.0044734. Epub 2012 Sep 6. PLoS One. 2012. PMID: 22970302 Free PMC article.
-
Azole and Amphotericin B MIC Values against Aspergillus fumigatus: High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure.Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01693-20. doi: 10.1128/AAC.01693-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33020164 Free PMC article.
-
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect.J Antimicrob Chemother. 2010 May;65(5):931-8. doi: 10.1093/jac/dkq046. Epub 2010 Feb 18. J Antimicrob Chemother. 2010. PMID: 20167587 Free PMC article.
-
UPC2 is universally essential for azole antifungal resistance in Candida albicans.Eukaryot Cell. 2014 Jul;13(7):933-46. doi: 10.1128/EC.00221-13. Epub 2014 Mar 21. Eukaryot Cell. 2014. PMID: 24659578 Free PMC article.
-
Molecular Diagnosis of Brettanomyces bruxellensis' Sulfur Dioxide Sensitivity Through Genotype Specific Method.Front Microbiol. 2018 Jun 11;9:1260. doi: 10.3389/fmicb.2018.01260. eCollection 2018. Front Microbiol. 2018. PMID: 29942296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical